Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system (CNS) and is responsible for long-term morbidity in 250-350,000 people in the United States. Although the precise etiology of MS is unknown, this inflammatory disorder is associated with histologic features suggestive of autoimmune destruction. Myelin-specific immune responses are demonstrable in the peripheral blood and cerebrospinal fluid of MS patients. Autoimmune T cell responses may be directed against various target antigens in the CNS, including myelin basic protein (MBP), proteolipid protein (PLP), and myelin oligodendrocyte glycoprotein (MOG). To understand the pathogenesis of MS, it is crucial to elucidate the fine specificity and exact nature of autoantigen specific responses. Recent powerful methodologies emerging in other areas of Immunology have enabled us to sensitively and specifically characterize human immune responses. We propose to apply these techniques to address important questions regarding the fine specificity, cytokine profile, and the T cell repertoire of responses in MS. In addition, dynamic evolution of these responses will be studied longitudinally in MS patients at different clinical stages of the disease, to study the pathogenic role of """"""""epitope spreading."""""""" CNS antigen-specific responses may sometimes be observed in healthy individuals, although these responses are qualitatively different. Prior work suggests that responses from healthy individuals may differ in their costimulatory requirements. Building on these results, we will elucidate the costimulatory requirements of autoreactive T cells and address intrinsic differences in the T cell repertoire in different sets of T cells. The Candidate will be primarily responsible for the formulation of experiments and data analysis and interpretation. His co-Mentors are well-established investigators in distinctive areas of Immunology. The University of Texas Southwestern Medical Center has an excellent environment for basic and clinical research. The Candidate has doctoral experience in Immunology research, specifically in an autoimmune murine model of multiple sclerosis and has recently finished residency and fellowship training in Hematopathology. He will utilize this career development award to further develop new expertise in cutting-edge technology and learn newer approaches in human Immunology, at the same time logically building on his past experience in autoimmunity, in a related area of human disease. This will greatly facilitate his eventual transition into an independent physician-scientist at an academic medical center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI049990-02
Application #
6511596
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
2001-07-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
2
Fiscal Year
2002
Total Cost
$117,990
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Sinha, Sushmita; Crawford, Michael P; Ortega, Sterling B et al. (2015) Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis. J Mult Scler (Foster City) 2:
Tennakoon, Deepani K; Mehta, Riyaz S; Ortega, Sterling B et al. (2006) Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J Immunol 176:7119-29
Karandikar, Nitin J; Kroft, Steven H; Yegappan, Subramanian et al. (2004) Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis. Blood 104:2007-9
Crawford, Michael P; Yan, Shirley X; Ortega, Sterling B et al. (2004) High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103:4222-31
Brenchley, Jason M; Karandikar, Nitin J; Betts, Michael R et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101:2711-20
Karandikar, Nitin J; Crawford, Michael P; Yan, Xiao et al. (2002) Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J Clin Invest 109:641-9